Location: Palo Alto, CA
CIK: 0001674712 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 13, 2024
Total Value: $1.208B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SLNO | Soleno Therapeutics Inc | 6,291,851 | $318M | 26.3% | $19.93 | +140.2% | Common | 834203309 |
| GERN | Geron Corp | 27,225,292 | $124M | 10.2% | $1.62 | +181.2% | Common | 374163103 |
| HRMY | Harmony Biosciences Holdings Inc | 2,606,247 | $104M | 8.6% | $36.16 | -2.9% | Common | 413197104 |
| — | Verona Pharma PLC | 3,549,758 | $102M | 8.5% | $6.97 | — | SPONSORED ADS | 925050106 |
| SVA | Sinovac Biotech Ltd. | 11,800,000 | $76.35M | 6.3% | $6.47 | 0.0% | SHS | P8696W104 |
| TERN | Terns Pharmaceuticals Inc | 6,895,746 | $57.51M | 4.8% | $11.04 | -25.5% | Common | 880881107 |
| TIL | Instil Bio Inc | 624,339 | $42.03M | 3.5% | $7.23 | +225.5% | Common | 45783C200 |
| DYN | Dyne Therapeutics Inc | 1,114,960 | $40.05M | 3.3% | $18.65 | +113.4% | Common | 26818M108 |
| VRDN | Viridian Therapeutics Inc | 1,678,207 | $38.18M | 3.2% | $15.47 | +5.7% | Common | 92790C104 |
| — | Avadel Pharmaceuticals PLC | 2,684,109 | $35.2M | 2.9% | $13.12 | — | ADR | G29687103 |
| SLN | Silence Therapeutics PLC | 1,105,454 | $20.1M | 1.7% | $19.65 | — | ADS | 82686Q101 |
| ZBIO | Zenas Biopharma Inc | 1,183,260 | $20.02M | 1.7% | $17.98 | 0.0% | Common | 98937L105 |
| ERAS | Erasca Inc | 6,756,756 | $18.45M | 1.5% | $2.16 | +30.5% | Common | 29479A108 |
| OLMA | Olema Pharmaceuticals Inc | 1,505,862 | $17.98M | 1.5% | $31.43 | -59.3% | Common | 68062P106 |
| — | Astria Therapeutics Inc | 1,552,685 | $17.1M | 1.4% | $10.21 | — | Common | 04635X102 |
| — | Tourmaline Bio Inc. | 591,882 | $15.22M | 1.3% | $26.18 | — | Common | 89157D105 |
| RZLT | Rezolute Inc | 2,797,704 | $13.57M | 1.1% | $1.28 | +259.7% | Common | 76200L309 |
| ORIC | Oric Pharmaceuticals Inc | 1,277,818 | $13.1M | 1.1% | $8.39 | +17.8% | Common | 68622P109 |
| SERA | Sera Prognostics Inc | 1,650,440 | $12.87M | 1.1% | $10.38 | -30.1% | Common | 81749D107 |
| COGT | Cogent Biosciences Inc | 1,122,471 | $12.12M | 1.0% | $8.55 | +13.9% | Common | 19240Q201 |
| ABEO | Abeona Therapeutics, Inc. | 1,842,751 | $11.65M | 1.0% | $5.10 | +2.3% | Common | 00289Y206 |
| CMPS | Compass Pathway PLC | 1,608,000 | $10.13M | 0.8% | $7.40 | — | SPONSORED ADS | 20451W101 |
| CELC | Celcuity Inc | 610,500 | $9.103M | 0.8% | $16.73 | -1.5% | Common | 15102K100 |
| DCTH | Delcath Systems, Inc. | 997,005 | $9.003M | 0.7% | $5.02 | +72.9% | Common | 24661P807 |
| CRVS | Corvus Pharmaceuticals Holdings | 1,497,268 | $7.906M | 0.7% | $3.59 | 0.0% | Common | 221015100 |
| — | Regulus Therapeutics Inc | 5,000,000 | $7.85M | 0.6% | $2.88 | — | Common | 75915K309 |
| ALXO | ALX Oncology Holdings Inc | 4,034,522 | $7.343M | 0.6% | $39.31 | -90.5% | Common | 00166B105 |
| CMPX | Compass Therapeutics Inc | 3,556,023 | $6.543M | 0.5% | $3.60 | -65.3% | Common | 20454B104 |
| IOBT | IO Biotech Inc | 6,173,439 | $6.482M | 0.5% | $5.62 | -77.6% | Common | 449778109 |
| — | Adverum Biotechnologies, Inc. | 833,333 | $5.85M | 0.5% | $14.14 | — | Common | 00773U207 |
| TRVI | Trevi Therapeutics Inc | 1,612,903 | $5.387M | 0.4% | $2.97 | 0.0% | Common | 89532M101 |
| VSTM | Verastem Inc | 1,538,461 | $4.6M | 0.4% | $6.94 | -60.9% | Common | 92337C203 |
| ENGN | Engene Holdings Inc. | 678,705 | $4.479M | 0.4% | $10.40 | -28.5% | Common | 29286M105 |
| CRBP | Corbus Pharmaceuticals Holdings | 166,794 | $3.441M | 0.3% | $42.06 | +21.7% | Common | 21833P301 |
| — | Bolt Therapeutics Inc | 3,521,291 | $2.282M | 0.2% | $32.91 | — | Common | 097702104 |
| — | Allakos Inc | 2,956,110 | $1.931M | 0.2% | $6.12 | — | Common | 01671P100 |
| — | Unicycive Therapeutics | 4,470,152 | $1.823M | 0.2% | $0.76 | — | Common | 90466Y103 |
| ALGS | Aligos Therapeutics Inc | 141,879 | $1.229M | 0.1% | $12.44 | 0.0% | Common | 01626L204 |
| CDXS | Codexis, Inc | 388,144 | $1.195M | 0.1% | $13.98 | -77.9% | Common | 192005106 |
| — | DBV Technologies SA | 1,354,437 | $948K | 0.1% | $0.80 | — | SPONSORED ADS | 23306J200 |
| QTTB | Q32 Bio Inc. | 20,559 | $917K | 0.1% | $13.78 | +166.7% | Common | 746964105 |
| TENX | Tenax Therapeutics Inc | 208,333 | $721K | 0.1% | $3.62 | 0.0% | Common | 88032L605 |
| DTIL | Precision Biosciences Inc | 4,675 | $41,888 | 0.0% | $12.24 | -21.3% | Common | 74019P207 |